Lourdes Riquelme, Author at Labiotech.eu

About

Spanish Biotechnologist with a MS in Genetics from Universidad Autonoma of Barcelona. My interests go from science to fashion and anything in between.

Articles by Lourdes Riquelme

News and Trends 25 Mar 2015

The Institut Pasteur and IntegraGen, allies to Strengthen High-Throughput Sequencing in Microbiology

IntegraGen and the Institut Pasteur signed an agreement for high-throughput sequencing in the field of Microbiology. IntegraGen will be responsible for the technical and operational implementation of high-throughput sequencing activities for use by the microbiology experts at the National Reference Center (NRC) at the Institut Pasteur. High-throughput sequencing will be the reference tool for analysis, […]

March 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 24 Mar 2015

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Rigontec has raised €4.8M in the second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor. The new investment brings the total Series A to €14.2M to the biopharmaceutical company that is developing RNA-based immunotherapeutics for the treatment of […]

March 24, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 23 Mar 2015

Life Sciences have a new big player: Joint Polish Investment Fund Management

Poland’s first Institutional Venture Capital Fund dedicated to Life Sciences announced today the first closing of its new venture capital fund at €38.5M. Joint Polish Investment Fund Management (JPIF), headed by Dr. Marek Orłowski, is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments. The fund […]

March 23, 2015 - 3 minutesmins - By Lourdes Riquelme

AOP Orphan Pharmaceuticals Confluence Pharmaceuticals Fragile X

News and Trends 23 Mar 2015

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

AOP Orphan Pharmaceuticals and Confluence Pharmaceuticals, signed today a definitive agreement to co-develop and market Confluence’s lead asset, a product for the treatment of Fragile X Syndrome in Europe and the Middle East. Confluence is an American biopharmaceutical company focused on developing therapeutic treatments for Fragile X Syndrome and Autism Spectrum Disorders. The company has […]

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 23 Mar 2015

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

University of Copenhagen released a vaccine candidate against the form of malaria that strikes pregnant women, for testing in humans. The vaccine candidate contains a malaria antigen made with ExpreS2ion Biotechnologies’ protein expression technology, ExpreS2. This vaccine candidate results from many years of research done by Professor Ali Salanti and his team at the Department […]

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 20 Mar 2015

Optibrium introduces the lastest version of StarDrop

Cambridge-based Optibrium has launched of version 6.1 of its StarDrop platform to guide researchers in the design of high quality compounds in drug discovery, agrochemicals and other chemistry fields. The latest release introduces the Matsy technology, based on matched molecular series analysis, which proposes strategies for chemical substitutions to optimise compound activity. Also included is […]

March 20, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 18 Mar 2015

Novartis’ Jakavi receives European Commission approval

Novartis received the approval from the European Commission for Jakavi (ruxolitinib) for the treatment of adult patients with Polycythemia Vera (PV) who are resistant to or intolerant of hydroxyurea. Jakavi is the first targeted treatment approved by the European Commission for these patients. PV is a rare and incurable blood cancer associated with an overproduction […]

March 18, 2015 - 2 minutesmins - By Lourdes Riquelme

New oncology neoliquid neoplus cancer diagnosis

News and Trends 17 Mar 2015

New Oncology finances its Genetic Test for Cancer Diagnosis

New Oncology completed a financing round to prepare the market launch of NEOliquid, a non-invasive blood test that identifies therapeutically actionable genome alterations in the circulating free tumor DNA (ctDNA) of cancer patients. New Oncology’s pan-cancer diagnostic platform NEOplus reliably detects actionable genome alterations from one single patient sample with short turn-around times. In contrast to […]

March 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Mar 2015

MISSION Appoints Paul Wallace as Chief Business Officer

Mission Therapeutics, a company focused on the discovery and development of modulators of the deubiquitylating (DUB) enzyme family for the treatment of cancer and other diseases, appointed Paul Wallace as Chief Business Officer. The appointment highlights the scope and productivity of Mission’s drug discovery platform. Dr. Wallace joins Mission to formulate future business strategy at […]

March 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 14 Mar 2015

Samsung Bioepis Submits a Biosimilar Candidate, to the European Medicines Agency

Samsung Bioepis announced their submission to the to the European Medicines Agency (EMA) for SB2, its Remicade (Infliximab) biosimilar candidate. This is the second biosimilar candidate Marketing Authorization Application (MAA) that Samsung Bioepis has submitted to the EMA. The MAA is based on results from an extensive head-to-head preclinical data package comparing SB2 to the originator, a […]

March 14, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 13 Mar 2015

Get prepared: Pi day is coming!

Pi day, the unofficial annual holiday commemorating the math constant π, has this year a special significance. It is celebrated on March 14th, or 3/14 in the month/day date format, as the three first numbers of the constant. Furthermore, a sequential time will also happen tomorrow, on 3/14/15 at 9:26:53, when the clock will display […]

March 13, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 13 Mar 2015

Orgenesis acquires MaSTherCell

Orgenesis acquired MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics based in Gosselies, Belgium, as part of the American company’s plan to increase its global presence and capabilities. The American and the Belgian companies have already been working jointly since last year to scale manufacturing of Orgenesis’ insulin-producing liver cells to fight diabetes. […]

March 13, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Lourdes Riquelme

About

Articles by Lourdes Riquelme

The Institut Pasteur and IntegraGen, allies to Strengthen High-Throughput Sequencing in Microbiology

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Life Sciences have a new big player: Joint Polish Investment Fund Management

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

A Vaccine against Placental Malaria made with ExpreS2ion’s Protein Expression Technology

Optibrium introduces the lastest version of StarDrop

Novartis’ Jakavi receives European Commission approval

New Oncology finances its Genetic Test for Cancer Diagnosis

MISSION Appoints Paul Wallace as Chief Business Officer

Samsung Bioepis Submits a Biosimilar Candidate, to the European Medicines Agency

Get prepared: Pi day is coming!

Orgenesis acquires MaSTherCell

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Lourdes Riquelme

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!